MediMatch AI: Revolutionizing Clinical Trial Recruitment

Spread the love

AI platform using NLP to match patients with clinical trials via EHR analysis. Targets pharma companies and CROs, reducing recruitment from months to days while ensuring compliance.

MediMatch AI tackles the €8B clinical trial recruitment challenge by leveraging NLP to analyze Electronic Health Records. This platform identifies eligible patients within days instead of months while automating HIPAA/GDPR compliance. Designed for pharmaceutical companies and research organizations, it promises to accelerate medical breakthroughs through intelligent matching algorithms.

Core functionality

AI-powered EHR analysis using NLP to identify eligible patients. Features include automated consent management, trial matching algorithms, HIPAA/GDPR-compliant data processing, and real-time recruitment dashboards. Blockchain integration ensures audit trails for consent management.

Target user and segment

Pharmaceutical companies (70% of target market)
Clinical Research Organizations – CROs (25%)
Research hospitals (5%)
Specialization: Oncology, rare diseases, chronic conditions

Recommended tech stack

Backend: Python (Django) + FHIR API for EHR integration
AI: spaCy/MedCAT for medical NLP, TensorFlow matching algorithms
Database: PostgreSQL with pgvector similarity search
Frontend: React.js + Tailwind CSS
Infrastructure: AWS HIPAA-compliant environment
Consent management: Hyperledger Fabric blockchain

Estimated MVP hours and costs

Total development: 2,400 hours at €100/hour = €240,000

Core development: 1,200 hours
Compliance certification: 300 hours
EHR integration: 400 hours
AI training: 500 hours

Timeline: 6-8 months

SWOT-analysis

Strengths: 90%+ match accuracy, recruitment time reduction, automated compliance
Weaknesses: EHR integration dependencies, high regulatory barriers
Opportunities: €8B market growing at 12% CAGR, real-world evidence expansion
Threats: Competition from Antidote/TriNetX, EHR vendors adding native features